NANOSPONGES : A NEW PATHWAY FOR NOVEL DRUG DELIVERY SYSTEM

Main Article Content

SATNAM SINGH
SIMRANJEET KAUR LOHAT

Abstract

The headway in nanotechnology lead to innovation of numerous measurements structures, to evade the above limitations,a down to earth approach has been created for the development of discrete functionalized particles, which have been named as 'nanosponges'. This medication conveyance framework will solubilize the medication, and lead to the treatment to the objective framework to satisfy the individual need of the patient and illness stage. Nanosponges are about minuscule particles with a nano size which are equipped for stacking wide assortment of medications. These small particles moves inside the body except if they arrive at the objective site and delivery the medication in a specific and controlled way, this is the explanation, they will be more powerful for a specific given measurements. These can convey both hydrophilic and hydrophobic medications. Nanosponge innovation has been utilized to examine the medication conveyance by oral organization, skin organization and parenteral organization. Nanosponges can be utilized as nanovesicles to forestall medication and protein corruption. Other significant property of Nano wipe is that they can work on the solvency of ineffectively water solvent medication. This article gives the outline of nanosponges , benefits , technique for prepration and uses of nanosponges in drug science.

Downloads

Download data is not yet available.

Article Details

How to Cite
SATNAM SINGH, & SIMRANJEET KAUR LOHAT. (2022). NANOSPONGES : A NEW PATHWAY FOR NOVEL DRUG DELIVERY SYSTEM. Innovat International Journal Of Medical & Pharmaceutical Sciences, 7(3), 9–12. Retrieved from https://www.innovatpublisher.com/index.php/iijmps/article/view/187
Section
Review Article(s)

References

Bolmal UB, Manvi FV, Kotha R, Palla SS, Paladugu A, Reddy KR. Recent advances in nanosponges as drug delivery systems. PCIApproved- IJPSN. 2013;6(1):1934-44. doi: 10.37285/ijpsn.2013.6.1.3.

Aldawsari HM, Eldwin B. SM Labibgs and el- kmel. Design and formulation of topical hydrogel integrating lemongrass loaded nanosphere with an enhanced antifungal effect in vitro / in vivo evaluation. Int J Nanomedicine. 2015;10:893-902.

Jenny A, Merima P, Albert F, Fracesio T. Role of β- cyclodextrin nanosponges in propylene photo oxidation. Carbohydr Polym. 2011;86(1):127-35.

Swaminathan S, Darandale S, Vavia PR. Nanosponge-aided drug delivery: a closer look. Pharm Formul Qual. 2012:12-5.

Waghmare SG, Nikhade RR. Dr. Satish and B. Kosalge. Nanosponges:a novel approach for controlled release drug delivery system. Int J Pharm Pharm Res. 2017;9(3):101-16.

Liang L, De-Pei L, Chih-Chuan L. Optimizing the delivery systems of chimeric RNA. DNA oligonucleotides beyond general oligonucleotidetransfer. Eur J Biochem. 2002;269:5753-8.

Sharma R, Roderick B, Pathak K. Evaluation of kinetics and mechanism of drug release from econazole nitrate nanosponges loaded Carbopol Hydrogel. Indian J Pharm Educ Res. 2011;45(1):25-31.

Alongi J, Poskovic M, Frache A, Trotta F. Roleof?- cyclodextrin nanosponges in polypropylene photooxidation. Carbohydr Polym. 2011;86(1):127-35. doi: 10.1016/j.carbpol.2011.04.022.

7, Benet LZ. BCS and BDDCS. Bioavailability and bioequivalence: focus on Physiological Factors and variability. Department of Biopharmaceutical sciences. University of California, San Francisco; 2007.

Renuka S, Roderick BW, Kamla P. Evaluation ofthe kinetics and mechanism of drug release from econazole nitrate nanosponge loaded carbapolhydrogel. Ind J Pharm Educ Res. 2011;45(1):25-31.

Sharma R, Pathak K. Polymeric nanosponges as analternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation. Pharm Dev Technol. 2011;16(4):367-76. doi: 10.3109/10837451003739289, PMID 20367024.

Torne SJ, Ansari KA, Vavia PR, Trotta F, Cavalli R. Enhanced oral paclitaxel bioavailability after administration of paclitaxel loaded nanosponges. Drug Deliv. 2010;17(6):419-25. doi: 10.3109/10717541003777233, PMID 20429848.

Ansari KA, Torne SJ, Vavia PR, Trotta F, Cavalli R. Paclitaxel loaded nanosponges: in-vitro characterization and cytotoxicity study on MCF-7cell line culture. Curr Drug Deliv. 2011;8(2):194-202. doi: 10.2174/156720111794479934, PMID 21235471.

Shankar S, Linda P, Loredana S, Francesco T, Pradeep V, Dino A et al. Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical Characterization, stability and cytotoxicity. Eur JPharm Biopharm. 2010;74:193-201.

Rosalba M, Roberta C, Roberto F, Chiara D, Piergiorgio P, Leigh E et al. Antitumor activity of nanosponge-encapsulated Camptotechin in human prostate tumors. Cancer Res. 2011;71:4431.

Khalid AA, Pradeep RV, Francesco T, Roberta C. Cyclodextrinbased nanosponges for delivery of resveratrol: in vitro

characterisation, stability, cytotoxicity and permeation Study. AAPS PharmSciTech. 2011;12(1):279-86.

Aritomi H, Yamasaki Y, Yamada K, Honda H, Khoshi M. Development of sustained release formulation of chlorpheniramine maleate using powder coated microsponges prepared by dry impact blending method. J Pharm Sci Technol. 1996;56(1):49-52.

Kiliçarslan M, Baykara T. The effect of the drug/polymer ratio on the properties of verapamil HCl loaded microspheres. Int J Pharm. 2003;252(1-2):99-109. doi: 10.1016/s0378-5173(02)00630-0, PMID 12550785.

Alongi J, Poskovic M, Frache A, Trotta F. Role of β-cyclodextrin nanosponges in polypropylene photooxidation. Carbohydr Polym. 2011;86(1):127-35. doi: 10.1016/j.carbpol.2011.04.022.

Trotta F, Cavalli R, Tumiatti W, Zerbinati O, Rogero C, Vallero R,inventors; Sea Marconi Technologies Sas, assignee.

Ultrasoundassisted synthesis of cyclodextrin-based nanosponges. EP;B1(2007, June 22):1786841.

Sharma R, Walker RB, Pathak K. Evaluation of the kinetics and mechanism of drug release from econazole nitrate nanosponges loaded carbapol hydrogel. Indian J Pharm Educ Res. 2011;45(1):25-31.

Sharma R, Pathak K. Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation. Pharm Dev Technol. 2011;16(4):367-76. doi: 10.3109/10837451003739289, PMID 20367024.

Cavalli R, Rogero CM, Mognetti B, Berta GN, Tumiatti V, Trotta F, inventors; Sea Marconi Technologies Sas, assignee. Cyclodextrinbased nanosponges as a vehicle for antitumoral drugs. WO2009/003656 A1. 2009 January 8.

Lala R, Thorat A, Gargote C. Current trends in β-cyclodextrin based drug delivery systems. Int J Res Ayurveda Pharm. 2011;2(5):1520-6.

Moya, -Ortega MD, Alvarez LC, Concherio A, Loftsson T.Cyclodextrin –based nanogels for pharmaceutical and biomedical applications. Int J Pharm. 2012;428(1):152-63.

Ansari KA, Vavia PR, Trotta F, Cavalli R. Cyclodextrin –based nanosponges for delivery of resveratrol: in vitro charecterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech2011;12(1):279-86. doi: 10.1208/s12249-011-9584-3, PMID 21240574.

[D.Lemboa, Swaminathan S, Donalisioa M. Encapsulation of acyclovir in new carboxylated cyclodextrin based nanosponges improves the agent antiviral efficacy. Int J Pharm. 2013;443(1- 2):262-72.

Mognetti B, Barberis A, Marino S, Berta G, Francia S, Trotta F et al. In vitro enhancement of anticancer activity of paclitaxel by a cremophor free cyclodextrin-based nanosponge formulations. J Inclus Phenom Macrocyclic Chem. 2012;74(1-4):201-10. doi: 10.1007/s10847-011-0101-9.

William K, Benjamin S, Eva H. Synthesis and Characterization of Nanosponges for Drug Delivery and CancerTreatment.www.Vanderbilt.edu [accessed on 20.12.2011].

Swaminathan S, Vavia PR, Trotta F, Torne S. Formulation of Betacyclodextrin based nanosponges of itraconazole. J Incl Phenom Macrocycl Chem. 2007;57(1-4):89-94. doi: 10.1007/s10847-006-

-9.